
(MedPage Today) — TORONTO — Numerous artificial intelligence (AI)-powered systems for diagnosing and monitoring Alzheimer’s disease and other dementias are now authorized by the FDA, but how these systems were developed — and therefore how…
Source link : https://www.medpagetoday.com/meetingcoverage/aaic/116746
Author :
Publish date : 2025-07-30 19:15:00
Copyright for syndicated content belongs to the linked
Source.